CGTX – cognition therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Will Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely? [Yahoo! Finance]
Cognition Therapeutics (NASDAQ:CGTX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Cognition Therapeutics Reaches Full Enrollment in Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
Cognition Therapeutics Presents Phase 3 Plan for Zervimesine (CT1812) in Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference
Cognition Therapeutics (NASDAQ:CGTX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Ricciardi Lisa
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Caggiano Anthony
Form 4 COGNITION THERAPEUTICS For: Dec 18 Filed by: Doyle John Brendan
Form 8-K COGNITION THERAPEUTICS For: Dec 16
Form S-3 COGNITION THERAPEUTICS
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.